Associations of albuminuria with interstitial lung abnormalities in older community-dwelling adults confounded by age

The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study was supported by grants R01-HLO77612 and RC1-HL100542 from the National Heart, Lung, and Blood Institute (NHLBI). The MESA Lung Fibrosis Study was funded by grants R01-HL103676 from the NHLBI. MESA projects are conducted and supported by the NHLBI in collaboration with MESA investigators. Support for MESA is provided by contracts 75N92020D00001, HHSN268201500003sI, N01-HC95159, 75N92020D00005, N01-HC95160, 75N92020D00002, N01-HC95161, 75N92020D00003, N01-HC95162, 75N92020D00006, N01-HC95163, 75N92020D00004, N01-HC95164, 75N92020D00007, N01-HC95165, N01-HC95166, N01-HC95167, N01-HC95168, N01-HC95169, UL1-TR000040, UL1-TR001079, UL1-TR001420, UL1TR001881, P30-DK063491 and R01-HL105756. MESA was also funded by National Center for Advancing Translational Sciences (National Institutes of Health (NIH)) grants UL1-TR-000040,UL1-TR-001079, and UL1-TR-001420. The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Molecular data for the TOPMed programme was supported by the NHLBI. Genome sequencing for "NHLBI TOPMed: The Multi-Ethnic Study of Atherosclerosis" (phs001416) was conducted at Broad Genomics (3U54HG003067-13S1, HHSN268201600034I). Core support for centralised genomic read mapping and genotype calling, along with variant quality metrics and filtering, were provided by the TOPMed Informatics Research Center (3R01HL-117626-02S1; contract HHSN268201800002I). Core support included phenotype harmonisation, data management, sample-identity quality control and general programme coordination, which were provided by the TOPMed Data Coordinating Center (R01HL-120393; U01HL-120393; contract HHSN268201800001I), as TOPMed MESA Multi-Omics (HHSN2682015000031/HSN26800004). The AGES-Reykjavik (Age, Gene/Environment Susceptibility-Reykjavik) study was supported by National Institute on Aging (NIH) contracts N01-AG-1-2100 and HHSN27120120022C, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association) and the Althingi (the Icelandic Parliament). Further support was by the Icelandic Research Fund, project grant 141513-051 (to G. Gu 3mundsson); the Landspitali Scientific Fund grants A-2019-029, A-2019-030, A-2020-018, A-2020-017, and A2021-018; as well as the University of Iceland Research Fund 2021 (to G. Gu 3mundsson) and the Eimskip University Fund (to G.T. Axelsson). The funding sources had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; or the decision to submit the manuscript for publication. Funding information for this article has been deposited with the Crossref Funder Registry.r UL1-TR-001079, and UL1-TR-001420. The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Molecular data for the TOPMed programme was supported by the NHLBI. Genome sequencing for "NHLBI TOPMed: The Multi-Ethnic Study of Atherosclerosis" (phs001416) was conducted at Broad Genomics (3U54HG003067-13S1, HHSN268201600034I) . Core support for centralised genomic read mapping and genotype calling, along with variant quality metrics and filtering, were provided by the TOPMed Informatics Research Center (3R01HL-117626-02S1; contract HHSN268201800002I) . Core support included phenotype harmonisation, data management, sample-identity quality control and general programme coordination, which were provided by the TOPMed Data Coordinating Center (R01HL-120393; U01HL-120393; contract HHSN268201800001I) , as TOPMed MESA Multi-Omics (HHSN2682015000031/HSN26800004) . The AGES-Reykjavik (Age, Gene/Environment Susceptibility-Reykjavik) study was supported by National Institute on Aging (NIH) contracts N01-AG-1-2100 and HHSN27120120022C, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association) and the Althingi (the Icelandic Parliament) . Further support was by the Icelandic Research Fund, project grant 141513-051 (to G. Gu 3mundsson) ; the Landspitali Scientific Fund grants A-2019-029, A-2019-030, A-2020-018, A-2020-017, and A2021-018; as well as the University of Iceland Research Fund 2021 (to G. Gu 3mundsson) and the Eimskip University Fund (to G.T. Axelsson) . The funding sources had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; or the decision to submit the manuscript for publication. Funding information for this article has been deposited with the Crossref Funder Registry.